This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The biopharmaceutical sector has made significant strides in developing and delivering effective drugs to improve health and combat diseases. However, the high cost of prescription drugs remains a significant barrier to access for many patients. One key solution to this issue lies in the role of generic drugs, which are significantly cheaper than branded products and can help reduce the financial burden on patients and the healthcare system.
A woman sat in our emergency department in agonizing pain, feeling shaky, nauseous, and weak — drug withdrawal was setting in. But she wasn’t a “junkie” or even a recreational drug user. She was in her mid-60s with advanced cancer in her ovaries that had spread to her abdomen, causing unbearable pain. She was my patient — let’s call her Teresa.
Despite advances in biologic therapies for severe asthma, significant unmet needs in asthma management remain, specifically with T-helper cell type 2 (T2)-low asthma, a subtype lacking typical inflammatory biomarkers. T2-low asthma presents unique challenges due to the absence of eosinophils and immunoglobulin E (IgE), which complicates both diagnosis and treatment.
Patients with Boots as a nominated pharmacy in England can now use the NHS app to see whether their prescription is ready to collect. The Pharmacistunderstands that Boots is the first supplier to roll out the functionality, with other suppliers planned to go live soon. More than 1,300 Boots pharmacies across England are now using […] The post NHS app prescription tracking rolls out across 1,300 Boots stores appeared first on The Pharmacist.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
In this episode, Ill discuss the IV vs nebulized route for tranexamic acid to treat hemoptysis. Episode 985: Is the IV or Nebulized Route Better When Giving Tranexamic Acid for Hemoptysis? Subscribe on iTunes , Android , or Stitcher In the treatment of hemoptysis, tranexamic acid has been given via the IV route and topically via nebulization. These two routes of administration were compared in a randomized controlled trial for the first time recently and the results were published in the journal
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! This is our last edition of the Readout until January 3, so I hope you have a lovely holiday! A thought: If you’re strapped for gift ideas, you could always gift three months to STAT+ for $10. Totally worth it.
Indias online pharmacy sector is on course to reduce operating losses (1) to below 10 per cent next fiscal from over 30 per cent in fiscal 2023, by sharpening focus on high-margin product segments and operational efficiencies. Cash losses, though on the decline, will continue for the next two fiscals due to high operational costs and intense competition.
Indias online pharmacy sector is on course to reduce operating losses (1) to below 10 per cent next fiscal from over 30 per cent in fiscal 2023, by sharpening focus on high-margin product segments and operational efficiencies. Cash losses, though on the decline, will continue for the next two fiscals due to high operational costs and intense competition.
Researchers in Australia have created an innovative drug delivery system that utilises a metalbiomolecule network (MBN) comprising of non-toxic metal ions together with phosphonate biomolecules, eg, DNA. As the MBN nanoparticles do not require complicated drug carriers and the materials are bio-compatible, the system has potential to boost successful drug development, according to first author Dr Wanjun Xu.
I’ve put together an approximately 20-minute video on the BCMTMS exam and what you can expect for 2025. General information on the 2025 BCMTMS Exam Who writes the exam? – National Board of Medication Therapy Management Eligibility ASK EMPLOYER IF THEY WILL HELP PURCHASE STUDY MATERIALS AND TEST COSTS!!!! About The BCMTMS Exam Content Domains […] The post 2025 BCMTMS Exam – How To Prepare?
Democratic lawmakers are calling for aggressive action to curb the increasing market power of UnitedHealth Group, including a possible breakup of a business empire they say is undermining competition, corrupting Medicare, and hurting vulnerable patients. The lawmakers, including several U.S. senators, argue the problems created by the company’s size and reach demand immediate steps to restore public confidence in the health care system.
On December 15, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy hosted Session 11 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, focusing on Good Practices In Quality Control. The event began with a keynote address by Dr Y K Gupta, President, AIIMS Jammu, and Principal Adviser, GARDP (Global Antibiotic Research and Development Partnership).
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Guardian review finds many online pharmacies flouting strict advertising rules that govern prescription-only drugs Weight-loss injections are being aggressively marketed to British consumers through often illegal promotions, in a practice experts have described as a wild west industry of drug selling. The booming market for jabs such as Wegovy and Mounjaro has triggered a price battle among online pharmacies, with even high-street chains cashing in on the soaring demand.
Chronic pain is a pervasive condition that affects millions of individuals worldwide, impacting their daily activities, emotional well-being, and overall quality of life. Traditional pain management strategies, often relying on over-the-counter medications or standard prescriptions, can fall short in providing effective relief or avoiding undesirable side effects.
WASHINGTON — Three large pharmaceutical companies left the brand-drug lobby PhRMA after the passage of Democrats’ drug pricing law in 2022. Following the exits, the organization collected $100 million less in annual membership dues, new tax filings show.
Namit Joshi assumed charge as Chairman of the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) during the 20 th Annual General Meeting held on December 23, 2024. He was elevated to the present post after serving two years as Vice Chairman of Pharmexcil. He currently holds the role of Commercial Director of Centrient Pharmaceuticals (Bain Capital company), managing region East which includes Asia and Africa.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Readers describe aggressive online promotions, Black Friday deals and special offers for prescription-only drugs After Andy King was told he was not eligible to receive weight-loss jabs on the NHS, he turned to the internet to order them privately. But before long, he was inundated with promotions. Every other advert on my social media feed is an offer to have a Black Friday deal on the drugs, he said.
Introduction Guide to Good Dispensing Practice, 2016 is developed to ensure that medicines are dispensed in accordance with the laws and guidelines in both government and private health care facilities in Malaysia. Labelling Requirements A ll dispensed medicine should be labelled according to the requirement stated by the law. Regulation 12 of Poisons Regulations 1952 Regulation 28 of Poisons (Psychotropic Substances) Regulations 1989 Label should contain Name, address and contact number of hosp
State lawmakers are fed up with federal inaction on artificial intelligence and are taking matters into their own hands. Lawmakers in Colorado, California, and Connecticut this year managed to pass AI-related bills, some quite sweeping in nature, even if the more ambitious ones were eventually killed by governors. And it’s not just blue states trying to fit guardrails onto the fast-moving AI industry.
Indian pharma players have increased their focus on innovative research and development (R&D). Historically, the majority of Indian companies used to execute their innovative research and development (R&D) from India. However, Indian companies have started establishing dedicated research companies in Western countries as well. Against this backdrop, the success of these dedicated research companies will compel more Indian companies to open new dedicated R&D companies in foreign count
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drugs such as Wegovy amd Mounjaro are an attractive prospect for online businesses and traditional pharmacies as well as the firms that make them It is a trend rooted in profit-making. Adverts featuring prescription-only weight-loss medications are splashed across the internet and it is causing concern among experts. But the question remains: who is driving the boom?
Seasonal allergies effect over 25% of people annually, and most experience some form of the common cold at some point as well, especially in the fall and winter seasons. The two have many similarities in symptoms, but by knowing what to look for thats unique to each, you can then create a plan to offset their effects and return quickly to full health and relief.
Introduction Consumers from private hospitals and clinics are provided with a huge range of brand choices , being it original or generic brand. However, some might prefer to use only the brand recommended by their family doctor. A customer may walk into your community pharmacy, requesting a brand that you unheard of before, such as Vocinti or "Cezti".
Akums Group has announced a strategic long-term agreement with a global pharma company (Akums has not revealed details of the partner yet) to manufacture and supply pharmaceutical formulations in the European market. Under this collaboration, Akums Group will produce and supply multiple SKUs of oral liquid formulations, which the partner company will market across various European countries.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Survey also finds one in seven have either taken such jabs themselves or know someone who has One in five Britons would use a weight-loss drug if it was free on the NHS, according to polling that also shows one in seven have either taken a jab themselves or know someone who has. But almost one in four people would not tell others if they were using them, suggesting the growing popularity of weight-loss jabs is accompanied by persistent stigma about them.
Discover how Generative AI is revolutionising the pharmaceutical industry and moving beyond hype towards widespread adoption in drug discovery and development. Learn more about the impact of GenAI.
BAL2420 is a lipooligosaccharide phosphoethanolamine transferase A (LptA) inhibitor, a new class of antibiotics with bactericidal activity against Gram-negative bacteria, including drug-resistant strains. The additional CARB-X funding is supported by the US Department of Health and Human Services (HHS); Biomedical Advanced Research and Development Authority; Antibacterials branch; Administration for Strategic Preparedness and Response; and includes contributions from Germanys Federal Ministry of
Mankind Pharma and Innovent Biologics have announced a partnership to exclusively license and commercialise sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient access to innovative therapeutic options in the region. Cancer has become a major health concern in India, with its burden projected to reach 29.8 million DALYs by 2025, according to The National Cancer Registry Progr
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
By Mark A. Tobolowsky & Frank J. Sasinowski The Winter Solstice, signifying the shortest day of the year, was Saturday, December 21. Although the earliest sunset of the year was actually in early December, this day also marked another premature sunset the beginning of the end of the rare pediatric disease priority review voucher program. As we blogged recently, the program has had scheduled sunset dates from its very beginning, which have been repeatedly extended.
This article reflects on the current state of diversity in Science, Technology, Engineering, and Mathematics (STEM) fields in 2024 and outlines a path forward for creating a more inclusive and equitable environment.
This collaboration aims to leverage Axcelead’s DegLead Platform, an integrated service solution designed for the next generation of small-molecule drug discovery, to support Astellas discovery efforts and contribute to the generation of drug candidate compounds. The platform addresses challenges in targeted protein degrader discovery, including synthetic technologies for the quick generation of compounds, diverse high-throughput screening systems, profiling assay systems, and compound libr
The burden of 12-month diagnosed prevalent cases of atopic dermatitis (AD) is forecast to increase at an annual growth rate (AGR) of 0.10 per cent from around 42.02 million cases in 2023 to 42.42 million cases in 2033 in the seven major markets (7MM*), according to GlobalData. GlobalDatas latest report, Atopic Dermatitis (AD): Epidemiology Forecast to 2033, reveals AD cases are rising because of the increasing prevalence of environmental and lifestyle risk factors and the increase in the inciden
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
98 
Let's personalize your content